Lipid Metabolism and Diabetes Complications

To begin the course, please login or register by clicking ENROLL. After logging in, you will be able to complete the pretest and view the video/documents. You will have the option to complete the posttest, evaluation and receive credit. Some courses may have an associated cost.

Step Status
Video/Document(s)
Posttest
Evaluation
Starts On: 7/1/2019: 12:00 AM
Ends On: 6/30/2020: 12:00 AM
Session Type: Internet Activity Enduring Material
Credits: 1
Description:

Faculty

Clay F. Semenkovich, MD
Professor, Medicine
Irene E. and Michael M. Karl Professor
Chief, Division of Endocrinology, Metabolism and Lipid Research
Professor, Cell Biology & Physiology
Disclosures
Financial Relationships:
- Speakers Bureau/Honoraria: Merck & Co.
- Consulting/Advisory Committees: Synergetics, Inc.

Presenters should indicate if speaking off label. This activity originated as a presentation at the CME activity, 45th Annual Washington University Kilo Diabetes Symposium, November 2-3, 2018, which was supported in part by AstraZeneca Pharmaceuticals.

Planning Committee

Jeffrey Blunt, PharmD
Financial Relationships: Nothing to disclose
Mary Jane Clifton, BA, CCRP
Financial Relationships: Nothing to disclose
Cynthia Herrick, MD, MPHS, FACP
Financial Relationships:
- Ownership Interest/Stock Equity: Cardinal Health, Inc.
Charles Kilo, MD, FACP, FACE
Financial Relationships: Nothing to disclose
Janet B. McGill, MD
Financial Relationships:
- Speakers Bureau/Honoraria: Aegerion Pharmaceuticals, Dexcom, Janssen Pharmaceuticals, Inc., Mannkind
- Consulting/Advisory Committees: Bayer HealthCare Pharmaceuticals, Inc, Dexcom, Novo Nordisk, Valeritas, Boehringer Ingelheim, Gilead
- Research Support/Grants: AstraZeneca, Dexcom, Medtronic, Novartis
Carol Recklein, RN, MHS, CDE
Financial Relationships:
- Speakers Bureau/Honoraria: Sanofi Aventis
- Consulting/Advisory Committees: Radius Health, Insulet
Amy E. Riek, MD, MSCI
Financial Relationships: Nothing to disclose

Objectives: The intended result of this activity is increased knowledge/competence, and upon completion of this course, participants should be able to:
  • Explain the benefits and risks of statin use in diabetes.
  • Compare specific treatment modalities that decrease vascular complications in diabetes.
  • Interpret the relationship between cholesterol intake and lipid metabolism.
  • List risks and benefits of aspirin in diabetes.
  • Analyze different fish oil preparations and their potential use in diabetes
Additional Information:
Target Audience: This course is planned inter-professionally for endocrinologists, internists, primary care and family practice physicians, nurses, nurse practitioners, certified diabetes educators, pharmacists, physician assistants and healthcare providers who participate in the care of persons with diabetes..

Publication Date: July 1, 2019
Expiration Date: June 30, 2020

Accreditation Information:
wustlcme
In support of improving patient care, Washington University School of Medicine in St. Louis is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Credit Awarded for this Activity:
Credit Statement:
American Medical Association (AMA Credit)
Washington University School of Medicine in St. Louis designates this enduring material for a maximum of 1 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
References:
  • AIM-HIGH Investigators. N Engl J Med 2011. DOI: 10.1056/NEJMoa1107579
  • Nathalie Bergeron et al. Circulation. 2015;132-1648-1666
  • N Engl J Med Volume 376(18):1713-1722 May 4, 2017
  • N Engl J Med Volume 371(22):2072-2082 November 27, 2014
Disclosure Information: It is the policy of Washington University School of Medicine in St. Louis, Continuing Medical Education, to ensure balance, independence, objectivity and scientific rigor in all its educational activities. All planners, faculty and other persons who may influence content of this CME activity have disclosed all relevant financial relationships with commercial interests. All disclosures have been reported and are indicated with their presentations. Any potential conflicts were addressed and resolved.

Presenters are also expected to openly disclose inclusion of discussion of any off-label, experimental, or investigational use of drugs or devices in their presentations.

Presentations are expected to be based on evidence that is accepted within the profession of medicine as adequate justification for their indication in the care of patients. All scientific research should conform to the generally accepted standards of experimental design, data collection and analysis. These presentations are not an endorsement of any commercial interests.

These presentations are the views and experiences of the presenters. The presenters' views do not represent the policy or position of Washington University School of Medicine in St. Louis. Washington University School of Medicine in St. Louis, Continuing Medical Education, is the provider for CME credits.
Categories: General Medicine


Powered By AI 4.5